Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Hypercalcemia in Primary Hyperparathyroidism
NCT00975221Phase 3Completed
- Sponsor
- Amgen
- Start
- Mar 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of cinacalcet in primary hyperparathyroidism (PHPT), sponsored by Amgen. Started Mar 2010; status: completed.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT00975221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975221.